Xun Lin
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Renal cell carcinoma treatment 33
- Prostate Cancer Treatment and Research 28
- Oncology 32
- PARP inhibition in cancer therapy 19
- Colorectal Cancer Treatments and Studies 5
- Inflammatory Biomarkers in Disease Prognosis 5
- Co-authors
- Ronit Simantov (25 shared papers)Toni K. Choueiri (22 shared papers)Rana R. McKay (21 shared papers)Robert J. Motzer (17 shared papers)Ewa Matczak (6 shared papers)Brian I. Rini (12 shared papers)Karim Fizazi (30 shared papers)Neal D. Shore (28 shared papers)
- Journals
- Journal of Clinical Oncology (33 papers)Clinical Genitourinary Cancer (10 papers)Annals of Oncology (7 papers)European Urology (6 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Xun Lin
92 papers receiving 2.3k citations
Xun Lin's Hit Papers
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 1.2k
- Hepatology 234
- Cancer Research 387
- Oncology 649
- Pathology and Forensic Medicine 144
Countries citing papers authored by Xun Lin
This map shows the geographic impact of Xun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xun Lin more than expected).
Fields of papers citing papers by Xun Lin
This network shows the impact of papers produced by Xun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xun Lin. The network helps show where Xun Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xun Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer Hit paper breakdown → | 2020 | 273 |
| 2 | 2009 | 221 | |
| 3 | 2016 | 126 | |
| 4 | 2013 | 113 | |
| 5 | 2013 | 111 | |
| 6 | 2013 | 109 | |
| 7 | 2015 | 107 | |
| 8 | 2015 | 77 | |
| 9 | 2019 | 74 | |
| 10 | 2011 | 72 | |
| 11 | 2014 | 59 | |
| 12 | 2014 | 57 | |
| 13 | 2015 | 52 | |
| 14 | 2022 | 46 | |
| 15 | 2018 | 46 | |
| 16 | 2015 | 40 | |
| 17 | 2017 | 39 | |
| 18 | 2016 | 35 | |
| 19 | 2018 | 33 | |
| 20 | 2017 | 33 |
About Xun Lin
Xun Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 93 papers that have together received 2.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (33 papers), Prostate Cancer Treatment and Research (28 papers), PARP inhibition in cancer therapy (19 papers), Cancer Genomics and Diagnostics (11 papers), Cancer, Lipids, and Metabolism (8 papers), Renal and related cancers (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Hepatology (234 citations), Cancer Research (387 citations), Oncology (649 citations) and Pathology and Forensic Medicine (144 citations). Xun Lin has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Ronit Simantov, Toni K. Choueiri, Rana R. McKay, Robert J. Motzer, Ewa Matczak, Brian I. Rini, Karim Fizazi, Neal D. Shore, María José Lechuga and Marina D. Kaymakcalan. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Annals of Oncology, European Urology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.